Polycythemia vera, a rare blood disorder, where careful medical oversight is appropriate
Each compounding pharmacy creates its own protocol without standardized ratios, concentrations, or quality assurance processes beyond state board requirements
Use may result in positive drug tests, sanctions, and disqualification from competition
Generally, drops of more than 20 mmHg systolic or 10 mmHg diastolic warrant attention, particularly if accompanied by symptoms like dizziness or fatigue
Our testing process is part of a larger quality-control system that includes supplier accountability, batch-level review, internal QA, professional storage, and in-house fulfillment